ArticleCureus2025
Neurocognitive Decline in Rapid Eye Movement (REM)-Predominant Obstructive Sleep Apnea (OSA) Versus Non-rapid Eye Movement (NREM)-Predominant OSA: A Comparative Study.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThe present study aims to investigate the distribution and characteristics of obstructive events across rapid eye movement (REM) and non-rapid eye movement (NREM) sleep stages and to assess their clinical and neurocognitive implications in patients with obstructive sleep apnea (OSA) in an Indian population. METHODOLOGY: This comparative study was conducted at the Department of Respiratory Medicine, Rajarajeswari Medical College and Hospital, Bangalore, from January to June 2025. It included 50 suspected OSA patients, screened using the STOP-BANG questionnaire. All participants underwent level 1 polysomnography and were classified as having either REM-predominant or NREM-predominant OSA based on the American Academy of Sleep Medicine (AASM) criteria. Neurocognitive and depression assessments were performed using the Mini-Cog test and the Patient Health Questionnaire-9 (PHQ-9). Statistical analysis was conducted using IBM SPSS Statistics for Windows, Version 22.0. The Mann-Whitney U test was applied for group comparisons, and a p-value of <0.05 was considered statistically significant.
resultsThe study included 50 patients, comprising 30 (60%) male patients and 20 (40%) female patients. Among the male patients, 27 (90%) had NREM-predominant OSA, while three (10%) had REM-predominant OSA. Among the female patients, 13 (65%) had NREM-predominant OSA, whereas seven (35%) had REM-predominant OSA. Female patients were more frequently presented with fatigue, whereas snoring was more commonly reported among male patients. The mean age was 50.63 ± 16.19 years for the NREM group and 52.80 ± 13.02 years for the REM group. The mean body mass index (BMI) was 30.47 ± 5.49 kg/m² in NREM OSA and 53.27 ± 63.43 kg/m² in REM OSA. The mean heart rate was 72.05 ± 8.22 beats per minute (bpm) in NREM OSA and 75.70 bpm in REM OSA. The NREM apnea-hypopnea index (AHI) was 5.27 ± 2.63 in REM OSA and 35.56 ± 29.17 in NREM OSA, with significantly higher values in the latter (p = 0.0001). The Mini-Cog score was considerably lower in REM OSA (1.30 ± 1.34) compared to NREM OSA (4.00 ± 1.28) (p = 0.0001). The PHQ-9 score was significantly higher in REM OSA (12.40 ± 4.20) than in NREM OSA (3.48 ± 2.70) (p = 0.0001).
conclusionThe detrimental effects of REM-predominant OSA on cognitive function are linked to reduced intracranial oxygen supply, fragmented sleep, and elevated oxidative stress and inflammation. Maintaining continuous positive airway pressure use in the early morning hours, when patients are most prone to discontinuation, is essential for optimal management. Our study emphasizes the need for neurocognitive screening in all newly diagnosed REM-predominant OSA patients to help prevent serious comorbidities. Early and appropriate intervention may mitigate the progression of neurocognitive impairment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.